Meiji Holdings Co Ltd: Segment Analysis

Meiji Holdings Co Ltd (Meiji) develops, manufactures and distributes dairy products, confectioneries, nutrition and pharmaceutical products.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Meiji's R&D focuses on the changing customer needs, lifestyle, and market trends. The company conducts R&D through its subsidiaries Meiji Co Ltd which conducts research on food and nutrition, and Meiji Seika Pharma Co Ltd which conducts research in pharmaceutical products. The company conducts R&D through its Wellness Science Labs. It focuses on researching and developing new pharmaceutical products with the aim of becoming the leading company in Japan. Its research activities also focus on enhancing pharmacological expertise, synthetic technology and microbial and bio-pharmaceutical technology in the pharmaceutical business. In food business, its R&D focuses on nutrition science expertise, material research into milk, lactic acid bacteria, cocoa and nutrition engineering technology. Its arm also focuses on microbial control, process technology and evaluation technologies. In FY2025, the company incurred expenses of JPY38,800 million on R&D, which as a percentage of revenue, stood at 3.4%.